Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Osteopore Ltd. ( (AU:OSX) ) just unveiled an update.
Osteopore Limited reported a 27% increase in revenue for the year ending December 2024, reaching a record high of $2,811,443. The company also reduced its net loss after tax by 33% to $3,244,684, attributed to improved cost management and a strategic reduction in sales and marketing expenses. This financial performance underscores Osteopore’s commitment to sustainable growth and its strengthened position in the regenerative medicine market.
More about Osteopore Ltd.
Osteopore Limited operates in the regenerative medicine industry, focusing on the development and commercialization of bioresorbable implants that facilitate natural tissue regeneration. The company is committed to innovation and optimizing operational efficiencies to enhance its market position.
YTD Price Performance: -35.00%
Average Trading Volume: 275,305
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$3.08M
Find detailed analytics on OSX stock on TipRanks’ Stock Analysis page.